Skip to main content
Caplight Logo









Chongqing Precision Biotech Co., Ltd.

Chongqing Precision Biotech Co., Ltd.

Private
ChongqingHealthcare & Life Scienceshttps://www.precision-biotech.com/

Last Round

Series C

Feb 4, 2024

Company Overview

Chongqing Precision Biotech Co., Ltd. is a biotechnology company that develops gene and cell therapy products, including CAR-T and CAR-NK cell therapies for the treatment of malignant tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

CAR-T therapycell therapyCAR-NKimmunotherapybiopharmaceuticaloncologyautologous cell therapycancer treatmentprecision medicinecell drug manufacturingclinical trialscell drug traceabilityliving drugsnext-gen cancer therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chongqing Precision Biotech Co., Ltd. Comparables

Compare Chongqing Precision Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Chongqing Precision Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Juventas Cell Therapy Ltd.
89%
PersonGen BioTherapeutics
88%
Shanghai Unicar-Therapy Bio-medicine Technology
87%

Chongqing Precision Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 4, 2024
Series B ExtensionOct 18, 2023
Series BApr 12, 2023
Series A ExtensionAug 3, 2020
Series AJan 1, 2020
Angel
Aug 4, 2016

Chongqing Precision Biotech Co., Ltd. Investors

Notable investors and investment history

Chongqing Precision Biotech Co., Ltd. investors
InvestorRounds
Oriental Fortune CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2020

    Completed a Series A Extension round of funding.

  • Jan 1, 2020

    Completed a Series A funding round.

Chongqing Precision Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Chongqing Precision Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Chongqing Precision Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChongqing
Employee Range5
Year Founded2016
Last FundingFeb 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?